Growing community of inventors

Piedmont, CA, United States of America

X Christopher Yu

Average Co-Inventor Count = 4.58

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 46

X Christopher YuMartin Vanderlaan (7 patents)X Christopher YuAilen M Sanchez (5 patents)X Christopher YuSusan C Fisher (5 patents)X Christopher YuChristopher A Teske (3 patents)X Christopher YuAtia Naim (3 patents)X Christopher YuJohn B Lowe (1 patent)X Christopher YuJayme Franklin (1 patent)X Christopher YuCorazon Victa (1 patent)X Christopher YuSaloumeh Kadkhodayan Fischer (1 patent)X Christopher YuAnnamarie Amurao (1 patent)X Christopher YuMartin Vanderlaan (1 patent)X Christopher YuJohn Lowe (1 patent)X Christopher YuX Christopher Yu (7 patents)Martin VanderlaanMartin Vanderlaan (13 patents)Ailen M SanchezAilen M Sanchez (12 patents)Susan C FisherSusan C Fisher (6 patents)Christopher A TeskeChristopher A Teske (3 patents)Atia NaimAtia Naim (3 patents)John B LoweJohn B Lowe (13 patents)Jayme FranklinJayme Franklin (3 patents)Corazon VictaCorazon Victa (2 patents)Saloumeh Kadkhodayan FischerSaloumeh Kadkhodayan Fischer (2 patents)Annamarie AmuraoAnnamarie Amurao (1 patent)Martin VanderlaanMartin Vanderlaan (2 patents)John LoweJohn Lowe (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genentech, Inc. (7 from 3,222 patents)


7 patents:

1. 12312399 - Methods and compositions comprising purified recombinant polypeptides

2. 11667706 - Methods of purifying recombinant anti-abeta antibodies

3. 10822404 - Methods and compositions comprising purified recombinant polypeptides

4. 10597447 - Compositions comprising purified recombinant IL-13 antibody

5. 10597446 - Method of treatment comprising purified recombinant IL-13 antibody

6. 10494429 - Compositions comprising purified anti-abeta monoclonal antibodies

7. 9920120 - Methods and compositions comprising purified recombinant polypeptides

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…